Proposed Information Collection Activity; Formative Data Collections for ACF Program Support (OMB #0970-0531), 64480-64481 [2020-22499]
Download as PDF
<![CDATA[
64480
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0100]
Advisory Committee on Immunization
Practices (ACIP); Amended Notice of
Meeting
Notice is hereby given of a
change in the meeting of the Advisory
Committee on Immunization Practices
(ACIP); October 28–29, 2020, 10:00
a.m.–5:30 p.m., EDT (times subject to
change), in the original Federal Register
notice. The meeting, which was
published in the Federal Register on
September 21, 2020, Volume 85,
Number 183, pages 59317–59318, is
being amended and should read as
follows:
SUMMARY:
The virtual meeting will be held
on October 28–30, 2020, from 10:00
a.m.–5:30 p.m., EDT (times subject to
change). The meeting is open to the
public.
Written comments must be received
on or before October 30, 2020.
ADDRESSES: For more information on
ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/
index.html.
You may submit comments, identified
by Docket No. CDC–2020–0100 by any
of the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2020–0100,
c/o Attn: October ACIP Meeting, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, MS H24–8,
Atlanta, GA 30329–4027.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
khammond on DSKJM1Z7X2PROD with NOTICES
DATES:
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Director, Strategic Business Initiatives
Unit, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–22464 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Formative Data Collections
for ACF Program Support (OMB
#0970–0531)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) proposes
to revise the existing overarching
generic clearance for Formative Data
Collections for ACF Program Support
(OMB #0970–0531) to increase the
estimated number of respondents and,
therefore, the overall burden estimate.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing
OPREinfocollection@acf.hhs.gov.
SUMMARY:
Alternatively, copies can also be
obtained by writing to the
Administration for Children and
Families, Office of Planning, Research
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests
emailed or written should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The goals of the generic
information collections under this
approval are to obtain information about
program and grantee processes or needs,
and to inform the following types of
activities, among others:
• Delivery of targeted assistance and
workflows related to program and
grantee processes, and the development
and refinement of recordkeeping and
communication systems.
• Planning for provision of
programmatic or evaluation-related
training or technical assistance (T/TA).
• Obtaining grantee or other
stakeholder input on the development
of program performance measures.
• Use of rapid-cycle testing activities
to strengthen programs in preparation
for summative evaluations.
ACF uses a variety of techniques such
as semi-structured discussions, focus
groups, surveys, templates, open-ended
requests, and telephone or in-person
interviews, in order to reach these goals.
Following standard OMB
requirements, OPRE will submit a
change request for each individual data
collection activity under this generic
clearance. Each request will include the
individual instrument(s), a justification
specific to the individual information
collection, and any supplementary
documents. OMB should review
requests within 10 days of submission.
Respondents: Example respondents
include: Current or prospective service
providers, training or T/TA providers,
grantees, contractors, current and
potential participants in ACF programs
or similar comparison groups, experts in
fields pertaining to ACF programs, key
stakeholder groups involved in ACF
projects and programs, individuals
engaged in program re-design or
demonstration development for
evaluation, state or local government
officials, or others involved in or
prospectively involved in ACF
programs.
ANNUAL BURDEN ESTIMATES
Estimated
total number of
respondents
Instrument
Semi-Structured Discussions and Focus Groups ...................................
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
PO 00000
Frm 00040
Fmt 4703
Number of
responses per
respondent
5,000
Sfmt 4703
E:\FR\FM\13OCN1.SGM
Average
burden hours
per response
1
13OCN1
Annual
burden hours
2
10,000
64481
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
ANNUAL BURDEN ESTIMATES—Continued
Estimated
total number of
respondents
Instrument
Interviews .................................................................................................
Questionnaires/Surveys ...........................................................................
Templates and Open-ended Requests ...................................................
Estimated Total Annual Burden
Hours: 20,875.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Social Security Act, Sec 1110
[42 U.S.C. 1310].
John M. Sweet Jr.
ACF/OPRE Certifying Officer.
[FR Doc. 2020–22499 Filed 10–9–20; 8:45 am]
BILLING CODE 4184–79–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–1736]
Potential Approach for Ranking of
Antimicrobial Drugs According to
Their Importance in Human Medicine:
A Risk Management Tool for
Antimicrobial New Animal Drugs;
Public Meeting; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is hosting a virtual public meeting
entitled ‘‘Potential Approach for
Ranking of Antimicrobial Drugs
According to Their Importance in
Human Medicine: A Risk Management
Tool for Antimicrobial New Animal
Drugs.’’ The purpose of the meeting is
to obtain early input from the public on
a potential revised approach for
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
Number of
responses per
respondent
2,500
2,500
650
considering the human medical
importance of antimicrobial new animal
drugs when assessing and managing the
antimicrobial resistance risks associated
with the use of antimicrobial drugs in
animals. The Agency is seeking public
input on a potential revised process for
ranking antimicrobials according to
their relative importance in human
medicine, on the potential criteria for
their ranking, and on the resulting
ranked list of antimicrobial drugs. A
concept paper describing this potential
revised process will be made available
for discussion at the public meeting and
can be obtained at the website listed in
section II of this notice.
DATES: The public meeting will be held
on November 16, 2020. Submit either
electronic or written comments on this
topic by January 15, 2021. Further
information regarding the meeting,
including the time the meeting will
start, the agenda, and how to register to
attend the meeting, can be found at
https://www.fda.gov/animal-veterinary/
workshops-conferences-meetings/fdapublic-meeting-potential-approachranking-antimicrobial-drugs-accordingtheir-importance-human. See the
SUPPLEMENTARY INFORMATION section for
registration dates and information.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before January 15,
2021. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of January 15, 2021.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Average
burden hours
per response
1
1.5
1
1
.5
10
Annual
burden hours
2,500
1,875
6,500
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked, and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–N–1736 for ‘‘Potential Approach
for Ranking of Antimicrobial Drugs of
According to Their Importance in
Human Medicine: A Risk Management
Tool for Antimicrobial New Animal
Drugs.’’ Received comments, those filed
in a timely manner (see ADDRESSES),
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ be publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Pages 64480-64481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22499]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Formative Data
Collections for ACF Program Support (OMB #0970-0531)
AGENCY: Office of Planning, Research, and Evaluation, Administration
for Children and Families, HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) proposes to
revise the existing overarching generic clearance for Formative Data
Collections for ACF Program Support (OMB #0970-0531) to increase the
estimated number of respondents and, therefore, the overall burden
estimate.
DATES: Comments due within 60 days of publication. In compliance with
the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995, ACF is soliciting public comment on the specific aspects
of the information collection described above.
ADDRESSES: Copies of the proposed collection of information can be
obtained and comments may be forwarded by emailing
[email protected]. Alternatively, copies can also be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All
requests emailed or written should be identified by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: The goals of the generic information collections under
this approval are to obtain information about program and grantee
processes or needs, and to inform the following types of activities,
among others:
Delivery of targeted assistance and workflows related to
program and grantee processes, and the development and refinement of
recordkeeping and communication systems.
Planning for provision of programmatic or evaluation-
related training or technical assistance (T/TA).
Obtaining grantee or other stakeholder input on the
development of program performance measures.
Use of rapid-cycle testing activities to strengthen
programs in preparation for summative evaluations.
ACF uses a variety of techniques such as semi-structured
discussions, focus groups, surveys, templates, open-ended requests, and
telephone or in-person interviews, in order to reach these goals.
Following standard OMB requirements, OPRE will submit a change
request for each individual data collection activity under this generic
clearance. Each request will include the individual instrument(s), a
justification specific to the individual information collection, and
any supplementary documents. OMB should review requests within 10 days
of submission.
Respondents: Example respondents include: Current or prospective
service providers, training or T/TA providers, grantees, contractors,
current and potential participants in ACF programs or similar
comparison groups, experts in fields pertaining to ACF programs, key
stakeholder groups involved in ACF projects and programs, individuals
engaged in program re-design or demonstration development for
evaluation, state or local government officials, or others involved in
or prospectively involved in ACF programs.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Estimated Number of Average burden
Instrument total number of responses per hours per Annual burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Semi-Structured Discussions and Focus Groups 5,000 1 2 10,000
[[Page 64481]]
Interviews.................................. 2,500 1 1 2,500
Questionnaires/Surveys...................... 2,500 1.5 .5 1,875
Templates and Open-ended Requests........... 650 1 10 6,500
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 20,875.
Comments: The Department specifically requests comments on (a)
whether the proposed collection of information is necessary for the
proper performance of the functions of the agency, including whether
the information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authority: Social Security Act, Sec 1110 [42 U.S.C. 1310].
John M. Sweet Jr.
ACF/OPRE Certifying Officer.
[FR Doc. 2020-22499 Filed 10-9-20; 8:45 am]
BILLING CODE 4184-79-P
